These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 31705872)

  • 21. Melt extrusion vs. spray drying: The effect of processing methods on crystalline content of naproxen-povidone formulations.
    Haser A; Cao T; Lubach J; Listro T; Acquarulo L; Zhang F
    Eur J Pharm Sci; 2017 May; 102():115-125. PubMed ID: 28259831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dissolution enhancement of fenofibrate by micronization, cogrinding and spray-drying: comparison with commercial preparations.
    Vogt M; Kunath K; Dressman JB
    Eur J Pharm Biopharm; 2008 Feb; 68(2):283-8. PubMed ID: 17574403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral bioavailability and pharmacodynamic activity of hesperetin nanocrystals generated using a novel bottom-up technology.
    Shete G; Pawar YB; Thanki K; Jain S; Bansal AK
    Mol Pharm; 2015 Apr; 12(4):1158-70. PubMed ID: 25785392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amorphous Formulation and in Vitro Performance Testing of Instantly Disintegrating Buccal Tablets for the Emergency Delivery of Naloxone.
    Alqurshi A; Kumar Z; McDonald R; Strang J; Buanz A; Ahmed S; Allen E; Cameron P; Rickard JA; Sandhu V; Holt C; Stansfield R; Taylor D; Forbes B; Royall PG
    Mol Pharm; 2016 May; 13(5):1688-98. PubMed ID: 26977787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Raman mapping of mannitol/lysozyme particles produced via spray drying and single droplet drying.
    Pajander JP; Matero S; Sloth J; Wan F; Rantanen J; Yang M
    Pharm Res; 2015 Jun; 32(6):1993-2002. PubMed ID: 25504535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hot melt extrusion technology for improved dissolution, solubility and "spring-parachute" processes of amorphous self-micellizing solid dispersions containing BCS II drugs indomethacin and fenofibrate: Profiles and mechanisms.
    Shi NQ; Wang SR; Zhang Y; Huo JS; Wang LN; Cai JH; Li ZQ; Xiang B; Qi XR
    Eur J Pharm Sci; 2019 Mar; 130():78-90. PubMed ID: 30684657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of manufacturing method for rapidly disintegrating oral tablets using the crystalline transition of amorphous sucrose.
    Sugimoto M; Narisawa S; Matsubara K; Yoshino H; Nakano M; Handa T
    Int J Pharm; 2006 Aug; 320(1-2):71-8. PubMed ID: 16750604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formulation and characterization of ternary solid dispersions made up of Itraconazole and two excipients, TPGS 1000 and PVPVA 64, that were selected based on a supersaturation screening study.
    Janssens S; Nagels S; Armas HN; D'Autry W; Van Schepdael A; Van den Mooter G
    Eur J Pharm Biopharm; 2008 May; 69(1):158-66. PubMed ID: 18164929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase separation of supersaturated solution created from amorphous solid dispersions: Relevance to oral absorption.
    Kawakami K; Sato K; Fukushima M; Miyazaki A; Yamamura Y; Sakuma S
    Eur J Pharm Biopharm; 2018 Nov; 132():146-156. PubMed ID: 30253186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Freeze-dried amorphous dispersions for solubility enhancement of thermosensitive API having low molecular lipophilicity.
    Kulthe VV; Chaudhari PD; Aboul-Enein HY
    Drug Res (Stuttg); 2014 Sep; 64(9):493-8. PubMed ID: 24443307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spray-freeze-drying production of thermally sensitive polymeric nanoparticle aggregates for inhaled drug delivery: effect of freeze-drying adjuvants.
    Cheow WS; Ng ML; Kho K; Hadinoto K
    Int J Pharm; 2011 Feb; 404(1-2):289-300. PubMed ID: 21093560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Manufacturing Amorphous Solid Dispersions with a Tailored Amount of Crystallized API for Biopharmaceutical Testing.
    Theil F; Milsmann J; Anantharaman S; van Lishaut H
    Mol Pharm; 2018 May; 15(5):1870-1877. PubMed ID: 29648833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of drug-polymer solubility from supersaturated spray-dried amorphous solid dispersions: A case study with Efavirenz and Soluplus®.
    Costa BLA; Sauceau M; Del Confetto S; Sescousse R; Ré MI
    Eur J Pharm Biopharm; 2019 Sep; 142():300-306. PubMed ID: 31247317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inverse gas chromatography a tool to follow physicochemical modifications of pharmaceutical solids: Crystal habit and particles size surface effects.
    Cares-Pacheco MG; Calvet R; Vaca-Medina G; Rouilly A; Espitalier F
    Int J Pharm; 2015 Oct; 494(1):113-26. PubMed ID: 26248145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Supersaturation Potential of Amorphous Active Pharmaceutical Ingredients after Long-Term Storage.
    Edueng K; Mahlin D; Gråsjö J; Nylander O; Thakrani M; Bergström CAS
    Molecules; 2019 Jul; 24(15):. PubMed ID: 31357587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Superiority of Mesoporous Silica-Based Amorphous Formulations over Spray-Dried Solid Dispersions.
    Zhang H; Li M; Li J; Agrawal A; Hui HW; Liu D
    Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crystallization of mannitol below Tg' during freeze-drying in binary and ternary aqueous systems.
    Pyne A; Surana R; Suryanarayanan R
    Pharm Res; 2002 Jun; 19(6):901-8. PubMed ID: 12134964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Producing Amorphous Solid Dispersions via Co-Precipitation and Spray Drying: Impact to Physicochemical and Biopharmaceutical Properties.
    Mann AKP; Schenck L; Koynov A; Rumondor ACF; Jin X; Marota M; Dalton C
    J Pharm Sci; 2018 Jan; 107(1):183-191. PubMed ID: 28711592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Method of Preparation of Amorphous Solid Dispersions on Mechanical Properties: Comparison of Coprecipitation and Spray Drying.
    Hou HH; Rajesh A; Pandya KM; Lubach JW; Muliadi A; Yost E; Jia W; Nagapudi K
    J Pharm Sci; 2019 Feb; 108(2):870-879. PubMed ID: 30244013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced oral bioavailability of fenofibrate using polymeric nanoparticulated systems: physicochemical characterization and in vivo investigation.
    Yousaf AM; Kim DW; Oh YK; Yong CS; Kim JO; Choi HG
    Int J Nanomedicine; 2015; 10():1819-30. PubMed ID: 25784807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.